GEMINI PHARMACEUTICALS, INC. – Trademark Portfolio
Entity Type: 03
GEMINI PHARMACEUTICALS, INC. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 3 Nice Classification classes. Currently, 7 trademarks are registered and 1 is pending. Notable registered marks include GEMINI, GEMLOQ, SINE OFF, SINE-OFF, and GEMINI PHARMACEUTICALS. The owner is based in NESCONSET, NY.
28 SOUTHERN BLVD.
NESCONSET, NY 11767
Showing of trademarks Trademarks
Trademark Classifications
GEMINI PHARMACEUTICALS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does GEMINI PHARMACEUTICALS, INC. have?
GEMINI PHARMACEUTICALS, INC. has 19 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 pending, 6 abandoned, 5 cancelled.
What trademark classes does GEMINI PHARMACEUTICALS, INC. file in?
GEMINI PHARMACEUTICALS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GEMINI PHARMACEUTICALS, INC.'s most well-known trademarks?
GEMINI PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as GEMINI, GEMLOQ, SINE OFF, SINE-OFF, and GEMINI PHARMACEUTICALS. These are among 7 currently registered trademarks in the portfolio.
What is GEMINI PHARMACEUTICALS, INC.'s trademark registration success rate?
GEMINI PHARMACEUTICALS, INC. has a 39% trademark registration rate, with 7 out of 18 resolved applications resulting in successful registration. Currently, 1 application is pending review.